ASCO President Sandra M. Swain, MD, FACP, introduces various study related to breast cancer research presented during the 49th Annual Meeting of the American Society of Clinical Oncology, being held in Chicago, May 31 – June 4, 2013.

  • Weekly, Low-dose, Paclitaxel Shows Similar Efficacy with Fewer Side Effects than Standard Biweekly Paclitaxel for Early-Stage Breast Cancer [Read Article]
  • Axillary Radiotherapy (ART) After Positive SNB Offers Comparable Disease Control as Lymph Node Surgery but With Lower Risk of Lymphedema for Women With Early-Stage Breast Cancer. [Read Article]
  • Study Shows Many African American Women have a Higher Risk for Breast Cancer – Suggests Importance of Screening Women and Relatives for Broader Range of Mutations. [Read Article]

Advertisement #5